09:56 EDT Adlai Nortye Ltd (ADR) trading resumes
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANL:
- Adlai Nortye to Unveil Cancer Drug Data at ASCO 2024
- Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
- Adlai Nortye announces first patient dosed in Phase II trial of palupiprant
- Adlai Nortye Ltd (ADR) trading resumes
- Adlai Nortye Ltd (ADR) trading halted, volatility trading pause